Evidence map›Paper›PMID 39179982›Full record

Trial reportBMC primary care2024

Addressing depression and comorbid health conditions through solution-focused brief therapy in an integrated care setting: a randomized clinical trial.

Zach W Cooper, Orion Mowbray, Mohammed K Ali, Leslie C M Johnson

Registry-linked trialAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in BMC primary care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05838222 (Implementation and Efficacy of Solution Focused Interventions Within an Integrated Behavioral Health Setting), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05838222 nacompletednot on this map

Implementation and Efficacy of Solution Focused Interventions Within an Integrated Behavioral Health Setting

TypeinterventionalSponsorUniversity of GeorgiaRan2023 to 2023Enrolled80ConditionsDepression, Diabetes Mellitus, Hypertension, Anxiety DisordersArmsSolution Focused Intervention, Treatment as Usual
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. A Scoping Review of Solution-Focused Measures.Journal of marital and family therapy · 2026
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zach W CooperSchool of Social Work, University of Georgia, Williams Street, Atlanta, GA, 30602, Georgia. zach.cooper@uga.edu.ORCID 0000-0001-7021-3536
Orion MowbraySchool of Social Work, University of Georgia, Williams Street, Atlanta, GA, 30602, Georgia.
Mohammed K AliDepartment of Family and Preventative Medicine, School of Medicine, Emory University, Atlanta, Georgia.
Leslie C M JohnsonDepartment of Family and Preventative Medicine, School of Medicine, Emory University, Atlanta, Georgia.

Funding

Translational Research Core - Engagement and Behavior ChangeP30DK111024 · NIDDK · EMORY UNIVERSITY · PI Mohammed Kumail Ali · 2016 to 2026
$13.4M
NIDDK NIH HHS P30 DK111024
6 · The paper itself

Abstract

backgroundCo-occurring physical and mental health conditions are common, but effective and sustainable interventions are needed for primary care settings. PURPOSE: Our paper analyzes the effectiveness of a Solution-Focused Brief Therapy (SFBT) intervention for treating depression and co-occurring health conditions in primary care. We hypothesized that individuals receiving the SFBT intervention would have statistically significant reductions in depressive and anxiety symptoms, systolic blood pressure (SBP), hemoglobin A1C (HbA1c), and body mass index (BMI) when compared to those in the control group. Additionally, we hypothesized that the SFBT group would have increased well-being scores compared to the control group.

methodsA randomized clinical trial was conducted at a rural federally qualified health center. Eligible participants scored ≥ 10 on the Patient Health Questionnaire (PHQ-9) and met criteria for co-occurring health conditions (hypertension, obesity, diabetes) evidenced by chart review. SFBT participants (n = 40) received three SFBT interventions over three weeks in addition to treatment as usual (TAU). The control group (n = 40) received TAU over three weeks. Measures included depression (PHQ-9) and anxiety (GAD-7), well-being (Human Flourishing Index), and SFBT scores, along with physical health outcomes (blood pressure, body mass index, and hemoglobin A1c).

resultsOf 80 consented participants, 69 completed all measures and were included in the final analysis. 80% identified as female and the mean age was 38.1 years (SD = 14.5). Most participants were white (72%) followed by Hispanic (15%) and Black (13%). When compared to TAU, SFBT intervention participants had significantly greater reductions in depression (baseline: M = 18.17, SD = 3.97, outcome: M = 9.71, SD = 3.71) and anxiety (baseline: M = 14.69, SD = 4.9, outcome: M = 8.43, SD = 3.79). SFBT intervention participants also had significantly increased well-being scores (baseline: M = 58.37, SD = 16.36, outcome: M = 73.43, SD = 14.70) when compared to TAU. Changes in BMI and blood pressure were not statistically significant.

conclusionThe SFBT intervention demonstrated efficacy in reducing depressive and anxiety symptoms and increasing well-being but did not affect cardio-metabolic parameters over a short period of intervention.

trial registrationThe study was pre-registered at ClinicalTrials.gov Identifier: NCT05838222 on 4/20/2023. *M = Mean, SD = Standard deviation.

Indexed as

AnxietyBody Mass IndexComorbidityDepressionGlycated HemoglobinAdultBlood PressureDelivery of Health Care, IntegratedDiabetes MellitusFemaleHumansHypertensionMaleMiddle AgedObesityPrimary Health CareGlycated HemoglobinBehavioral interventionComorbid disordersDepressionIntegrated behavioral healthPrimary care

Identifiers

PMID39179982
PMCPMC11342549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.